Estimated Impact of Nirsevimab on the Incidence of Respiratory Syncytial Virus Infections Requiring Hospital Admission in Children < 1 Year, Weeks 40, 2023, to 8, 2024, Spain
Mazagatos, Clara, Mendioroz, Jacobo, Rumayor, Mercedes Belén, Gallardo García, Virtudes, Álvarez Río, Virginia, Cebollada Gracia, Ana Delia, Batalla Rebollo, Noa, Barranco Boada, María Isabel, Pérez‐Martínez, Olaia, Lameiras Azevedo, Ana Sofía, López González‐Coviella, Nieves, Castrillejo, Daniel, Fernández Ibáñez, Ana, Giménez Duran, Jaume, Ramírez Córcoles, Cristina, Ramos Marín, Violeta, Larrauri, Amparo, Monge, Susana, Basile, Luca, García Comas, Luis, Lorusso, Nicola, Pacheco Martínez, María del Carmen, Rodríguez Martí, Cristina, Linares Dópido, Juan Antonio, Sánchez‐Migallon Naranjo, Alonso, Otero‐Barrós, María Teresa, Lopez Torrijos, Miriam, Rivas Wagner, Eva, Hermoso Castro, Luisa F., Huerta Huerta, Marta, Reina Prieto, Jorge, Gómez Juárez, Ana, Ruiz Nuñez, Aranzazu, González Carril, Fernando, Imaz Goienetxea, Liher, Ibáñez Pérez, Ana Carmen, Berradre Saenz, Belén, Puma Olguin, Tania, Pérez Gimeno, Gloria, Galindo Carretero, Silvia, Vega Piris, Lorena, Lozano, Marcos
Published in Influenza and other respiratory viruses (01.05.2024)
Published in Influenza and other respiratory viruses (01.05.2024)
Get full text
Journal Article